|
Market Closed -
Other stock markets
|
After hours 00:00:42 | |||
| 430.02 USD | -6.13% |
|
428.50 | -0.35% |
| 12-03 | Alnylam Pharmaceuticals Announces Changes to Board of Directors | CI |
| 12-03 | Alnylam Pharmaceuticals announces changes to board of directors | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.13% | -5.40% | -2.86% | -5.50% | +82.75% | +67.81% | +80.67% | +235.82% | +325.64% | 56.81B | |
| -1.26% | -5.70% | +7.92% | +35.06% | +29.22% | +20.67% | +168.32% | +568.18% | +1,054.48% | 893B | |
| -0.15% | -1.81% | +8.07% | +13.19% | +39.41% | +35.03% | +13.78% | +33.04% | +96.86% | 486B | |
| -1.31% | -0.88% | +1.81% | +6.35% | +25.56% | +26.64% | +34.42% | +107.19% | +293.72% | 394B | |
| -0.16% | +1.21% | +13.70% | +17.58% | +24.11% | +23.29% | +4.10% | +3.54% | +18.10% | 336B | |
| +1.18% | -0.23% | +4.89% | +14.96% | +31.52% | +28.65% | +21.26% | +71.84% | +212.62% | 280B | |
| +0.29% | +0.90% | +4.85% | +5.00% | +20.81% | +19.89% | +25.36% | +31.82% | +28.18% | 253B | |
| -0.79% | -2.85% | +14.66% | +17.65% | -0.55% | -4.04% | -10.75% | +18.93% | +85.02% | 246B | |
| -0.52% | -2.96% | +1.10% | -12.03% | -52.27% | -61.91% | -35.35% | +37.96% | +52.95% | 207B | |
| -2.63% | -4.82% | +0.32% | +14.65% | +23.25% | +17.85% | +12.49% | +40.31% | +101.59% | 173B | |
| -0.02% | -2.53% | +1.98% | +4.58% | +31.20% | +31.54% | +35.45% | +98.12% | +17.06% | 150B | |
| -1.00% | +1.98% | +5.49% | +4.97% | -2.86% | +0.16% | -50.23% | -39.45% | -20.78% | 147B | |
| -0.42% | -3.44% | -4.17% | +3.00% | -11.25% | -9.40% | -6.24% | +2.05% | +7.66% | 118B | |
| -2.95% | +3.86% | +7.95% | +11.84% | +9.77% | -4.34% | +37.57% | +92.33% | +258.54% | 112B | |
| -0.92% | +5.06% | +10.67% | +10.60% | -8.65% | -12.98% | -35.32% | -15.46% | -25.55% | 105B | |
| -0.67% | -0.66% | +1.98% | +21.19% | +34.20% | +30.66% | +23.95% | +3.35% | +9.85% | 97.31B | |
| -0.45% | +0.45% | +13.11% | +21.47% | +16.97% | +20.31% | +125.35% | +60.81% | +488.99% | 86.79B | |
| -.--% | +1.73% | - | - | - | - | - | - | - | 63.66B | |
| +1.36% | +0.84% | +1.43% | -13.62% | +36.08% | +26.11% | +60.69% | -16.78% | +302.48% | 58.65B | |
| +0.81% | +0.51% | +7.48% | -0.40% | +7.51% | +8.94% | +9.88% | +15.79% | -22.83% | 45.17B | |
| Average | -0.23% | -0.62% | +5.28% | +8.97% | +17.73% | +13.94% | +27.13% | +71.02% | +172.87% | 215.46B | |
| Weighted average by Cap. | -0.32% | -1.68% | +6.36% | +14.84% | +20.19% | +16.14% | +46.20% | +153.42% | +313.82% |
- Stock Market
- Equities
- ALNY Stock
- Sector Alnylam Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition